ID23804A - Penanganan diabetes dengan tiazolidindion sekretagog insulin dan penghambat alfa glukosidase - Google Patents

Penanganan diabetes dengan tiazolidindion sekretagog insulin dan penghambat alfa glukosidase

Info

Publication number
ID23804A
ID23804A IDW20000077A ID20000077A ID23804A ID 23804 A ID23804 A ID 23804A ID W20000077 A IDW20000077 A ID W20000077A ID 20000077 A ID20000077 A ID 20000077A ID 23804 A ID23804 A ID 23804A
Authority
ID
Indonesia
Prior art keywords
tiazolidindion
obligators
diabetes management
glucosidase
alfa
Prior art date
Application number
IDW20000077A
Other languages
English (en)
Inventor
Robin Edwin Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ID23804A publication Critical patent/ID23804A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
IDW20000077A 1997-07-18 1998-07-16 Penanganan diabetes dengan tiazolidindion sekretagog insulin dan penghambat alfa glukosidase ID23804A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9715298A GB9715298D0 (en) 1997-07-18 1997-07-18 Novel method of treatment

Publications (1)

Publication Number Publication Date
ID23804A true ID23804A (id) 2000-05-11

Family

ID=10816170

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000077A ID23804A (id) 1997-07-18 1998-07-16 Penanganan diabetes dengan tiazolidindion sekretagog insulin dan penghambat alfa glukosidase

Country Status (27)

Country Link
EP (1) EP1001784A1 (id)
JP (1) JP2001510160A (id)
KR (1) KR20010021952A (id)
CN (1) CN1263467A (id)
AP (1) AP2000001735A0 (id)
AR (2) AR016350A1 (id)
AU (1) AU8449098A (id)
BG (1) BG104062A (id)
BR (1) BR9810292A (id)
CA (1) CA2297133A1 (id)
CO (1) CO4940489A1 (id)
DZ (1) DZ2563A1 (id)
EA (1) EA200000140A1 (id)
GB (1) GB9715298D0 (id)
HU (1) HUP0003626A3 (id)
ID (1) ID23804A (id)
IL (1) IL133907A0 (id)
MA (1) MA24608A1 (id)
NO (1) NO20000230D0 (id)
OA (1) OA11312A (id)
PE (1) PE99499A1 (id)
PL (1) PL338140A1 (id)
SK (1) SK612000A3 (id)
TR (1) TR200000133T2 (id)
UY (1) UY25101A1 (id)
WO (1) WO1999003478A1 (id)
ZA (1) ZA986364B (id)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
PT1133312E (pt) 1999-06-21 2007-11-30 Lilly Co Eli Uso sinergístico de tiazolidinodionas com péptido 1 semelhante ao glucagon e os seus agonistas para tratar diabetes não insulino-dependente
DE122008000018I1 (de) * 2000-01-21 2008-08-14 Novartis Pharma Ag Zusammensetzungen bestehend aus Dipeptidylpeptidase-IV Inhibitoren und Antidiabetica
CA2401356A1 (en) * 2000-02-24 2001-08-30 Takeda Chemical Industries, Ltd. Combination drug
JP4917712B2 (ja) * 2000-02-24 2012-04-18 武田薬品工業株式会社 併用医薬
BRPI0206432A2 (pt) 2001-01-12 2016-10-25 Sun Pharmaceutical Ind Ltd métodos para administrar dois ou mais agentes terapêuticos ativos e para tratar diabetes melito ou sintomas associados com diabetes melito em um humano e sistema de liberação espaçada de medicamento
FR2832930A1 (fr) * 2001-12-03 2003-06-06 Lipha Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
KR100952090B1 (ko) 2003-10-31 2010-04-13 다케다 야쿠힌 고교 가부시키가이샤 인슐린 감작제, 인슐린 분비촉진제 및 폴리옥시에틸렌소르비탄 지방산 에스테르를 함유하는 고체 제제
CN101103993B (zh) * 2006-07-14 2011-03-30 北京华安佛医药研究中心有限公司 降糖药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE151634T1 (de) * 1991-08-26 1997-05-15 Upjohn Co Flüssiges nahrungsmittel, das 3- guanidinopropionsäure enthält
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
AR019724A2 (es) 2002-03-13
DZ2563A1 (fr) 2003-02-15
PE99499A1 (es) 1999-12-18
PL338140A1 (en) 2000-09-25
WO1999003478A1 (en) 1999-01-28
CN1263467A (zh) 2000-08-16
AP2000001735A0 (en) 2000-01-16
HUP0003626A3 (en) 2001-12-28
KR20010021952A (ko) 2001-03-15
ZA986364B (en) 2000-01-17
AR016350A1 (es) 2001-07-04
JP2001510160A (ja) 2001-07-31
CA2297133A1 (en) 1999-01-28
EA200000140A1 (ru) 2000-06-26
NO20000230L (no) 2000-01-17
UY25101A1 (es) 2000-12-29
GB9715298D0 (en) 1997-09-24
SK612000A3 (en) 2000-07-11
BR9810292A (pt) 2000-09-19
NO20000230D0 (no) 2000-01-17
TR200000133T2 (tr) 2000-09-21
AU8449098A (en) 1999-02-10
EP1001784A1 (en) 2000-05-24
MA24608A1 (fr) 1999-04-01
OA11312A (en) 2003-10-24
BG104062A (en) 2000-11-30
HUP0003626A2 (hu) 2001-05-28
IL133907A0 (en) 2001-04-30
CO4940489A1 (es) 2000-07-24

Similar Documents

Publication Publication Date Title
ID23372A (id) Pengobatan diabetes dengan tiazolidindion dan metformin
ID24428A (id) Engontrol suhu dan kelembaban lewat peningkatan yang disertai pemanasan-ulang
TR199801144A3 (tr) Hizli etki girisli yeni ensülin türevleri.
FI972292A (fi) Diabeteksen hallinta
TR25602A (tr) Özel yeni polikarbonatlarin diger termoplastikler veya elastomerlerle karisimlari
ID21361A (id) Baterai dan metode pembuatannya
GB2331606B (en) Computer systems with e-mail capabilities
ID23953A (id) Asam 5-alkil-2-arilaminofenilasetat dan turunannya
DE69828839D1 (de) Einwegpatrone mit Stösseln für Befestigungselemente
DE29707002U1 (de) Schlüsselstruktur mit Beleuchtungsfunktion
IS4475A (is) Plastsprauta með yfirloki
DE69533260D1 (de) Subkutane glucose-elektrode
DK0963211T3 (da) Hypodermisk injektionssystem
ID18421A (id) Pembuatan asam akrilat dan asam metakrilat
DE69817432D1 (de) Cycloolefinpolymere und deren Verwendung
PT845475E (pt) Glicanos de inositol com actividade do tipo insulina
ID23804A (id) Penanganan diabetes dengan tiazolidindion sekretagog insulin dan penghambat alfa glukosidase
HK1030003A1 (en) Homopolymers with high photoinduceable double refraction
ID17573A (id) Elastomer-elastomer poliuretan/urea yang diperbaiki dengan panas dan kelembaban dengan sifat-sifat fisika yang ditingkatkan
FR2718358B1 (fr) Seringue à usage unique à aiguille rétractable.
ID23951A (id) Pengobatan diabetes dengan rosiglitazon dan insulin
DE69814318D1 (de) Festelektrolyt mit innerer Referenzkammer und Elektroden auf Innen- und Aussenflächen
DE69829545D1 (de) Kupplung mit vergrössster Rückhaltevorrichtung
ID24198A (id) Penanganan diabetes dengan tiazolidindion dan sulfonilurea
DE69812304T2 (de) Härtbare Silikonelastomere mit niedrigem Druckverformungsrest